| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Benzetimide Hydrochloride |
鹽酸芐替米特 |
5633-14-7 |
詳細(xì)
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
詳細(xì)
|
| vanin-1 inhibitor |
vanin-1 inhibitor |
2173134-00-2 |
詳細(xì)
|
| BAY-218 |
CPD3504 |
2162982-11-6 |
詳細(xì)
|
| AER-271 |
AER-271 |
634913-39-6 |
詳細(xì)
|
| Danicopan |
Danicopan |
1903768-17-1 |
詳細(xì)
|
| AT-007 |
AT-007 |
2170729-29-8 |
詳細(xì)
|
| GSK-2894631A |
GSK-2894631A |
2101626-26-8 |
詳細(xì)
|
| DSP-2230 |
DSP-2230 |
1233231-30-5 |
詳細(xì)
|
| KL1333 |
KL1333 |
1800405-30-4 |
詳細(xì)
|
| GSK3145095 |
GSK3145095 |
1622849-43-7 |
詳細(xì)
|
| NCC007 |
NCC007游離態(tài) |
2342583-66-6 |
詳細(xì)
|
| AZD-7648 |
AZD-7648 |
2230820-11-6 |
詳細(xì)
|
| SPASTAZOLINE |
SPASTAZOLINE |
2351882-11-4 |
詳細(xì)
|
| LIXIVAPTAN |
利伐普坦 |
168079-32-1 |
詳細(xì)
|
| GS-4361 |
GS-4361 |
2291164-02-6 |
詳細(xì)
|
| PF-06835919 |
PF-06835919 |
2102501-84-6 |
詳細(xì)
|
| PK68 |
PK68 |
2173556-69-7 |
詳細(xì)
|
| Licogliflozin |
1291094-73-9 |
1291094-73-9 |
詳細(xì)
|
| PF-06882961 |
PF-06882961 |
2230198-02-2 |
詳細(xì)
|
| CA4948 |
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)- |
1801344-14-8 |
詳細(xì)
|
| ERK-IN-1 |
ERK-IN-1 (COMPOUND B) |
1715025-32-3 |
詳細(xì)
|
| Seltorexant |
JNJ-42847922 |
1293281-49-8 |
詳細(xì)
|
| CC90001 |
CC90001 |
1403859-14-2 |
詳細(xì)
|
| EST73502 |
化合物EST73502 HCL |
2307458-82-6 |
詳細(xì)
|
| DS-1971a |
DS-1971a |
1450595-86-4 |
詳細(xì)
|
| BAY 2416964 |
AHR antagonist 3 |
2242464-44-2 |
詳細(xì)
|
| CC-90011 |
CC-90011 |
2097523-60-7 |
詳細(xì)
|
| LML134 |
LML-134 |
1542135-76-1 |
詳細(xì)
|
| EC-5026 |
EC-5026 |
1809885-32-2 |
詳細(xì)
|
| BMS-615 |
BMS-615 |
2180127-82-4 |
詳細(xì)
|
| VU6015929 |
Benzamide, 4-fluoro-3-[[[5-(1-methyl-1H-pyrazol-3-yl)-3-pyridinyl]methyl]amino]-N-[3-(trifluoromethoxy)phenyl]- |
2442597-56-8 |
詳細(xì)
|
| Tavapadon |
他伐帕敦 |
1643489-24-0 |
詳細(xì)
|
| suvn-911 |
化合物SUVN-911 |
2414674-71-6 |
詳細(xì)
|
| SR-4835 |
SR-4835 |
2387704-62-1 |
詳細(xì)
|
| YP001 |
YP001 |
1192171-69-9 |
詳細(xì)
|
| BMS-986242 |
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]- |
1923844-48-7 |
詳細(xì)
|
| PF-9363 |
PF-9363 |
2569009-58-9 |
詳細(xì)
|
| GLPG2938 |
GLPG2938 |
2130996-00-6 |
詳細(xì)
|
| MIPS-521 |
MIPS-521 |
1146188-19-3 |
詳細(xì)
|
| Lu AF27139 |
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF |
2097117-06-9 |
詳細(xì)
|
| IACS-13909 |
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl- |
2160546-07-4 |
詳細(xì)
|
| Bocidelpar |
化合物BOCIDELPAR |
2095128-20-2 |
詳細(xì)
|
| SR1664 |
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
1338259-05-4 |
詳細(xì)
|
| Complement factor D-IN-2 |
2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-2-pyridinyl)-, (1R,3S,5R)- |
1903742-34-6 |
詳細(xì)
|
| KN-62 |
1-[N,O-二(5-異喹啉磺?；?-N-甲基-L-型酪氨酸]-4-苯基哌嗪 |
127191-97-3 |
詳細(xì)
|
| SKF89976A hydrochloride |
1 - (4,4 - 二苯基-3 - 丁烯基)- 3 -哌啶鹽酸鹽 |
85375-15-1 |
詳細(xì)
|
| RY785 |
RY785 |
1393748-80-5 |
詳細(xì)
|
| GLUT inhibitor-1 |
GLUT抑制劑1 |
2421141-40-2 |
詳細(xì)
|
| I-BET567 |
化合物I-BET567 |
1887237-54-8 |
詳細(xì)
|
| GSK251 |
GSK251 |
2125968-05-8 |
詳細(xì)
|
| SGK1-IN-4 |
化合物SGK1-IN-4 |
1628048-93-0 |
詳細(xì)
|
| JQKD-82 |
JQKD-82 |
2410512-38-6 |
詳細(xì)
|
| Ximelagatran |
希美加群 |
192939-46-1 |
詳細(xì)
|
| AZD5305 |
AZD-5305 |
2589531-76-8 |
詳細(xì)
|
| AMP-945 |
AMP-945 |
1393653-34-3 |
詳細(xì)
|
| YTX-465 |
YTX-465 |
2225824-53-1 |
詳細(xì)
|
| ML339 |
化合物ML339 |
2579689-83-9 |
詳細(xì)
|
| SCD1 inhibitor-3 |
化合物SCD1 INHIBITOR-3 |
1282606-48-7 |
詳細(xì)
|
| HBX 41108 |
7-氯-9-氧代-9H-茚并[1,2-B]吡嗪-2,3-二甲腈 |
924296-39-9 |
詳細(xì)
|
| RS 67333 hydrochloride |
RS 67333鹽酸鹽 |
168986-60-5 |
詳細(xì)
|
| CJ033466 |
CJ 033466 |
519148-48-2 |
詳細(xì)
|
| SB-747651A dihydrochloride |
SB-747651A二鹽酸鹽 |
1781882-72-1 |
詳細(xì)
|
| Azidamfenicol |
疊氮氯霉素 |
13838-08-9 |
詳細(xì)
|
| INE963 |
化合物INE963 |
2640567-43-5 |
詳細(xì)
|
| GSK329 |
化合物 T24109 |
1268490-12-5 |
詳細(xì)
|
| Methan-d3-amine hydrochloride |
甲胺-d3-胺鹽酸鹽 |
7436-22-8 |
詳細(xì)
|
| BAY-179 |
化合物BAY-179 |
|
詳細(xì)
|
| SBI-425 |
化合物 T16859 |
1451272-71-1 |
詳細(xì)
|
| ACH-000143 |
化合物ACH-000143 |
2225836-30-4 |
詳細(xì)
|
| Nifeviroc |
Nifeviroc |
934740-33-7 |
詳細(xì)
|
| SHR0302 |
化合物SHR0302 |
1445987-21-2 |
詳細(xì)
|
| Methyl-d3-p-toluenesulfonate |
D3-對甲苯磺酰甲酯 |
7575-93-1 |
詳細(xì)
|
| tert-Butyl 5-bromo-2-methylbenzoate |
2-甲基-5-溴苯甲酸叔丁酯 |
1202551-75-4 |
詳細(xì)
|
| 6-chloro-2-methylpyridazin-3(2H)-one |
6-氯-2-甲基-2H-噠嗪-3-酮 |
10071-38-2 |
詳細(xì)
|
| (tert-Butyl ((1S,2S)-2-aminocyclohexyl)carbamate) |
(1S,2S)-BOC-1,2-環(huán)己二胺 |
180683-64-1 |
詳細(xì)
|
| 6-Bromo-1H-Indazole-3-Carbaldehyde |
6-溴-1H-吲唑-3-甲醛 |
885271-72-7 |
詳細(xì)
|
| N1,N1,2-trimethylpropane-1,2-diamine dihydrochloride |
N1,N1,2-三甲基-1,2-丙二胺鹽酸鹽 |
75975-36-9 |
詳細(xì)
|
| 2-(diMethylphosphoryl)aniline |
2-(二甲基氧磷基)苯胺 |
1197953-47-1 |
詳細(xì)
|
| (2-((2,5-Dichloropyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide |
(2-((2,5-二氯嘧啶-4-基)氨基)苯基)二甲基膦氧化物 |
1197953-49-3 |
詳細(xì)
|
| 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole |
6-溴-4-氟-1-異丙基-2-甲基-1H-苯并[d]咪唑 |
1231930-33-8 |
詳細(xì)
|
| 2-bromo-3,4-dihydro-6-hydroxynaphthalen-1(2H)-one |
2-溴-3,4-二氫-6-羥基萘-1(2H)-酮 |
1093227-38-3 |
詳細(xì)
|
| 2-bromo-N-ethyl-5-methoxyaniline |
2-溴-N-乙基-5-甲氧基苯胺 |
|
詳細(xì)
|
| 2-(4-(bromomethyl)phenyl)ethyl]carbamic acid tert-butyl ester |
[2-(4-(broMoMethyl)phenyl)ethyl]carbaMic acid tert-butyl ester |
914103-95-0 |
詳細(xì)
|
| 4-Fluoro-1-isopropyl-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole |
4-氟-1-異丙基-2-甲基-6-(4,4,5,5-四甲基-1,3,2-二氧硼雜環(huán)戊烷-2-基)-1H-苯并[d]咪唑 |
1231930-37-2 |
詳細(xì)
|
| Raltegravir Intermediate；(Benzyl [1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate) |
[1-[4-[[(4-氟芐基)氨基]羰基]-5-羥基-1-甲基-6-氧代-1,6-二氫嘧啶-2-基]-1-甲基乙基]氨基甲酸芐酯 |
518048-02-7 |
詳細(xì)
|
| Elacestrant 2HCl；RAD1901 HCl salt |
RAD-1901 |
1349723-93-8 |
詳細(xì)
|
| Elacestrant |
RAD-1901 |
722533-56-4 |
詳細(xì)
|
| Raltegravir Intermediate ；Propanoic acid, 2,2-dimethyl-, 2-(1-amino-1-methylethyl)-4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-1-methyl-6-oxo-5-pyrimidinyl ester |
雷特格韋-RT9 |
1172131-64-4 |
詳細(xì)
|
| Raltegravir potassium |
雷特格韋鉀鹽 |
871038-72-1 |
詳細(xì)
|
| 3-hydroxypyrazine-2-carboxamide |
3-羥基吡嗪-2-甲酰胺 |
55321-99-8 |
詳細(xì)
|
| 6-chloro-3-hydroxypyrazine-2-carboxamide |
6-氯-3-氧代-3,4-二氫吡嗪-2-甲酰胺 |
259793-90-3 |
詳細(xì)
|
| XL092 |
XL092 |
2367004-54-2 |
詳細(xì)
|
| PS-5505 |
PXS-5505二鹽酸鹽 |
2409964-23-2 |
詳細(xì)
|
| GSK8612 |
GSK8612 |
2361659-62-1 |
詳細(xì)
|
| Glutathione synthesis-IN-1 |
化合物GLUTATHIONE SYNTHESIS-IN-1 |
2632968-72-8 |
詳細(xì)
|
| FHD-286 |
FHD-286 |
2671128-05-3 |
詳細(xì)
|
| CDK4/6-IN-6 |
CDK4/6-IN-6 |
2380321-51-5 |
詳細(xì)
|
| KL11743 |
KL11743 |
1369452-53-8 |
詳細(xì)
|
| MDR652 |
化合物MDR-652 |
1933528-96-1 |
詳細(xì)
|